SMAD3 and Alzheimer disease: Our findings provide information on brain vascular expression changes at a single nucleus level in AD, uncover vascular-astrocytic interactions in the GVU, provide cross-species experimental validations for pericytic SMAD3-astrocytic VEGFA perturbations as a mechanism that may contribute to BBB disintegrity in AD.